Gentian Diagnostics ASA | GENT Logo | Annual Report & Investor Relations Data

Gentian Diagnostics ASA | GENT Annual Report & Investor Relations Data

ISIN

NO0010748866

Ticker

GENT

Sector

Health Care

Industry

Biotechnology

Country

Norway

Year Founded

2001

Gentian Diagnostics ASA (GENT)
Company Overview & Profile

Company Description

Gentian is a Norwegian IVD company that specialises in developing and manufacturing turbidimetric assays that enable clinical lab professionals to achieve greater operational efficiency, thus providing faster patient results to clinicians. The current portfolio and pipeline of diagnostic reagents span areas of kidney disease, cardiac disease, inflammation, infection and veterinary medicine.

By leveraging both our expertise in Particle-Enhanced Turbidimetric Immunoassays (PETIA) and proprietary nanoparticle technology, we develop immunoassays that enable users to transition from traditional low volume immunology platforms to fully automated clinical chemistry instruments. The typical Gentian customer enjoys shorter turnaround times, streamlined workflows and improved cost efficiency.

Served Area

Worldwide

Headquarters

PB 733
1509, Moss
Norway

Gentian Diagnostics ASA (GENT)
Filings & Annual Reports

Filters

View all types
Type Document Details Language Filing Date File Number

Get Early API Access

Access comprehensive European stock market filings data through a single, powerful API.

1,5M+

filings covered

18

European countries

30min

max latency

1 API

for all filings

Request Early Access

Limited spots available. Join now!

Gentian Diagnostics ASA (GENT)
Leadership: Management & Supervisory Board

No Leadership Information Available

We currently don't have information about the management or supervisory board for this company. This information will be updated as soon as it becomes available.

Gentian Diagnostics ASA (GENT)
Stock & Investor Information

ISIN

NO0010748866

LEI

5967007LIEEXZXHNM861

Stock Exchange Listings

Oslo Børs

Industry Classification

Gentian Diagnostics ASA (GENT)
Related Companies & Peer Group

4SC AG Logo

4SC AG

VSC

Sector

Health Care

Country

Germany

ISIN

DE000A3E5C40

Founded

1997

4SC focuses on the development of novel small molecule drugs that target key mechanisms of cancer development, such as histone …

ABIONYX Pharma Logo

ABIONYX Pharma

ABNX

Sector

Health Care

Country

France

ISIN

FR0012616852

Founded

ABIONYX Pharma is a new-generation biotech company that aims to contribute to health through innovative therapies in indications where there …

Abliva Logo

Abliva

ABLI

Sector

Health Care

Country

Sweden

ISIN

SE0002575340

Founded

2000

Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when …

AB Science Logo

AB Science

AB

Sector

Health Care

Country

France

ISIN

FR0010557264

Founded

2001

AB Science is a late-clinical-stage French company founded in 2001 by a team of scientists with the goal of developing …

Acticor Biotech Logo

Acticor Biotech

ALACT

Sector

Health Care

Country

France

ISIN

FR0014005OJ5

Founded

Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of …

Active Biotech Logo

Active Biotech

ACTI

Sector

Health Care

Country

Sweden

ISIN

SE0001137985

Founded

1998

Active Biotech develops pharmaceutical products within medical areas where the immune system is of significant importance, including cancer and inflammatory …